OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults
Yíngyún Caì, Seme Diallo, Kim Rosenthal, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Closed Access | Times Cited: 7
Yíngyún Caì, Seme Diallo, Kim Rosenthal, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Closed Access | Times Cited: 7
Showing 7 citing articles:
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial
Ghady Haidar, S. Thomas, Paul Loubet, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Ghady Haidar, S. Thomas, Paul Loubet, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
Delphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
Pathogens and Immunity (2024) Vol. 10, Iss. 1, pp. 1-11
Open Access | Times Cited: 7
Delphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
Pathogens and Immunity (2024) Vol. 10, Iss. 1, pp. 1-11
Open Access | Times Cited: 7
Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
Sofiia N. Rizatdinova, Alina E. Ershova, Irina V. Astrakhantseva
Biomolecules (2025) Vol. 15, Iss. 1, pp. 135-135
Open Access
Sofiia N. Rizatdinova, Alina E. Ershova, Irina V. Astrakhantseva
Biomolecules (2025) Vol. 15, Iss. 1, pp. 135-135
Open Access
Escape of SARS-CoV-2 variants KP1.1, LB.1 and KP3.3 from approved monoclonal antibodies
Delphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Delphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Structural Immunology of SARS ‐CoV ‐2
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access | Times Cited: 1
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access | Times Cited: 1
Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?
Line Lundegaard Bang, Lone Wulff Madsen, Rune M. Pedersen, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 9, pp. 102512-102512
Open Access
Line Lundegaard Bang, Lone Wulff Madsen, Rune M. Pedersen, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 9, pp. 102512-102512
Open Access
